Haiqing Zhang

Haiqing Zhang

Auto-generated profile, based on publicly available information

Haiqing Zhang


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in International Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
LLLu Liu
Lu Liu
YYYong Yu
Yong Yu
MZMeng Zhao
Meng Zhao
DZDongmei Zheng
Dongmei Zheng
XZXu Zhang
Xu Zhang
HZHaiqing Zhang
Haiqing Zhang
Objectives. To evaluate the effect of levothyroxine (LT4) replacement therapy on nonalcoholic fatty liver disease (NAFLD) in subclinical hypothyroidism (SCH) patients.Methods. This study was a post hoc analysis of a randomized controlled trial and involved 33 significant and 330 mild SCH patients. All of the significant SCH patients received LT4supplement. The mild SCH patients were grouped as LT4treated or not. After 15 months of follow-up, prevalence of NAFLD in each group was reevaluated. Subgroup analysis was conducted in mild SCH patients with dyslipidemia.Results. After treatment with LT4, the prevalence of NAFLD in significant SCH patients reduced from 48.5% to 24.2% (p=0.041). In mild SCH patients, prevalence of NAFLD and serum alanine aminotransferase (ALT) was not significantly affected by LT4supplementation. Nonetheless, mild SCH patients with dyslipidemia who received LT4treatment experienced decreases in the prevalence of NAFLD and serum ALT levels (p<0.05for both). In contrast, these parameters remained comparably stable in patients who were not treated.Conclusion. LT4supplementation has benefits on NAFLD in significant SCH patients or mild SCH patients with dyslipidemia. For NAFLD patients with SCH, appropriate supplementation of LT4may be an effective means of controlling NAFLD. The original trial was registered with ClinicalTrials.gov (NCT01848171).

8 August 2013 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
RRRuizhen Ren
Ruizhen Ren
XJXiuyun Jiang
Xiuyun Jiang
XZXu Zhang
Xu Zhang
QGQingbo Guan
Qingbo Guan
CYChunxiao Yu
Chunxiao Yu
JZJiajun Zhao
Jiajun Zhao

10 September 2018 in Current Vascular Pharmacology
Verified
Journal Article
Closed access
PDF file
PSPing Song
Ping Song
LXLan Xu
Lan Xu
XJXu Jin
Xu Jin
HZHai-Qing Zhang
Hai-Qing Zhang
CYchunxiao yu
chunxiao yu
XZXu Zhang
Xu Zhang
Objective: To investigate the characteristics of body fat distribution and the relationship between body fat index and Atherogenic Index of Plasma (AIP) in Type 2 Diabetes Mellitus (T2DM) patients. Methods: A total of 316 participants were divided into a T2DM group and a non-diabetes group (controls). According to the Visceral Fat Area (VFA), all participants were further divided into VFA ≥100 cm2 and VFA <100 cm2 groups. To compare the differences of blood lipid, blood glucose, body fat index and AIP between the 2 groups, single factor correlation analysis was used to determine the correlation between the indexes and AIP, and multiple linear regression was used to analyse the correlation between the related factors and AIP. Results: The body fat index (including body fat content, Percentage of Body Fat (PBF), Waist to Hip Fat Ratio (WHR) and VFA), Triglyceride (TG), Fasting Insulin (FINS), Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and AIP in T2DM group were significantly higher than in the control group, while High Density Lipoprotein Cholesterol (HDL-C) level was significantly higher in the control group. In the VFA ≥ 100 cm2 group, TG, Low Density Lipoprotein Cholesterol (LDL-C), FINS, HOMAIR and AIP were all higher than that in the VFA <100 cm2 group. There was a positive correlation between AIP and VFA, body fat content, percentage of body fat, and WHR, respectively. There was also a negative correlation between AIP and HDL-C, which was not related to age, sex, Fasting Glucose (FPG), glycosylated haemoglobin (HbA1c), Total Cholesterol (TC), LDL-C and course of disease. Compared with the VFA <100 cm2 group, the VFA ≥100 cm2 group had higher blood Uric Acid (UA) levels and UA was positively correlated with VFA. After correcting the effect of UA on AIP, VFA was still an independent related factor of AIP, and VFA increased the risk of atherosclerosis by increased UA. Conclusion: T2DM patients have the abnormal distribution of body fat and a high VFA, which was associated with AIP.

13 September 2016 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
NGNannan Gao
Nannan Gao
YYYong Yu
Yong Yu
BZBingchang Zhang
Bingchang Zhang
ZYZhongshang Yuan
Zhongshang Yuan
HZHaiqing Zhang
Haiqing Zhang
JZJiajun Zhao
Jiajun Zhao
The prevalence of cardiovascular disease has been increasing worldwide. As a common pathogenic risk factor, dyslipidemia played a great role in the incidence and progress of these diseases. We investigated to achieve accurate and up-to-date information on the prevalence of dyslipidemia and its associations with other lipid-related diseases in rural North China. Using a complex, multistage, probability sampling design, we conducted a large-scale cross-sectional study of 8528 rural participants aged over 18 years in Shandong Province. Prevalence and characteristics of dyslipidemia were demonstrated. The odds ratios between dyslipidemia types and lipid-related diseases were further analyzed by logistic regression. Among the overall population, 45.8 % suffered from dyslipidemia. The prevalence of lipid abnormality (including high and very high levels) was 18.6, 12.7, 9.8 and 12.7 % for total cholesterol (TC), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol and triglycerides (TG), respectively. Among all participants with dyslipidemia, 23.9 % were aware, only 11.5 % were treated, 10.0 % were controlled. For subjects with dyslipidemia, the risk for non-alcoholic fatty liver disease (NAFLD) was highest with a 3.3-fold over that of non-dyslipidmia (OR = 3.30, P < 0.001); followed by hyperuricemia and diabetes mellitus (DM), while with 2-fold increase (OR = 1.99, P < 0.001; OR = 1.92, P < 0.001); with only 1.5-fold risk for atherosclerosis (AS) (OR = 1.47, P < 0.001). The presence of high cholesterol was mainly associated with AS, while abnormal TG was correlated with NAFLD and DM. Dyslipidemia has become a serious public health issue in rural North China. The rapid increase of high TC and incremental risk of high TG may contribute to the epidemic of AS, NAFLD and DM. It is imperative to develop individualized prevention and treatment guidelines according to dyslipidemia phenotypes.

1 March 2016 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
NGNannan Gao
Nannan Gao
ZYZhongshang Yuan
Zhongshang Yuan
XTXulei Tang
Xulei Tang
XZXiaoming Zhou
Xiaoming Zhou
MZMeng Zhao
Meng Zhao
LGLing Gao
Ling Gao

27 March 2016 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
JYJianmei Yang
Jianmei Yang
XZX. Zhang
X. Zhang
ZLZhanfeng Liu
Zhanfeng Liu
ZYZhongshang Yuan
Zhongshang Yuan
YSYongfeng Song
Yongfeng Song
JZJiajun Zhao
Jiajun Zhao